Spots Global Cancer Trial Database for cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1
Every month we try and update this database with for cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors | NCT00612703 | Cancer | ARQ 197 | 18 Years - | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | |
| A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors | NCT00612703 | Cancer | ARQ 197 | 18 Years - | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
